Status:
UNKNOWN
Impact of Containment and the Current Epidemic on the Sexual Risk-taking of People Using PrEP to Prevent HIV Infection.
Lead Sponsor:
Tourcoing Hospital
Conditions:
PREP
Eligibility:
All Genders
18+ years
Brief Summary
People using PrEP to prevent HIV infection have sexual risk-taking behaviors that motivated the prescription of PrEP. Both containment and the current epidemic may affect the sexual behavior of people...
Eligibility Criteria
Inclusion
- People using PrEP for HIV prevention being followed up at Tourcoing hospital
- Having given their consent to participate in this study
- Beneficiary of a social insurance plan or entitled person
Exclusion
- Minor patient
- Refusal to participate
- Trusteeship
- Curatorship
Key Trial Info
Start Date :
February 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT04772326
Start Date
February 16 2021
End Date
September 1 2022
Last Update
May 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CH Tourcoing
Tourcoing, France